Rare Disease Day Turns Spotlight on Research

Rare Disease

Diagnoses for rare diseases frequently are elusive even when genetically based; definitive therapeutic options are nonexistent for more than 95% of rare diseases, and symptomatic therapy, including support services may have limited utlility, says Michael Murphy, M.D., Ph.D., chief medical and scientific officer, Worldwide Clinical Trials.

White Papers

Five Emerging Trends Within Cardiovascular Research

Cardiovascular, Clinical Research

Five emerging trends within the drug discovery/drug development paradigm are highlighted in this review—each reinforcing the need for therapeutically focused, methodologically rigorous, and highly efficient project teams for product evaluation and commercialization.